Biomay AG Receives FDA Approval for Manufacturing and Supply of Recombinant Cas9 NucleaseVienna, Austria – Biomay AG, a privately owned Contract Development and Manufacturing Organization (CDMO), announced today that it has successfully obtained approval from the U.S. Food and Drug Administration (FDA) for the manufacturing,